Link to the PDF with some thoughts below: fda.gov/media/193343/d The FDA reviewed 5 reports with 109 humans: 24 healthy volunteers rectal 53-person Ulcerative Colitis trial rectal 17 knee-pain patients intra-articular 12 bladder-pain patients intravesical 2 healthy volunteers IVThe FDA has 4 broad reasons against BPC: 1
"It works on key centers of the brain to help reduce emotional eating and cravings," explains Brynna Connor, MD, an Austin-based integrative health expert and ambassador for NorthWestPharmacy.com
Maintenance dose in patients with type 2 diabetes mellitus and chronic kidney disease: After at least 4 weeks on the 0.5 mg dose, increase to 1 mg subcutaneously once a week
It is administered via Intravenous (IV) injection (drip or slow push) or Intramuscular (IM) injection
Results RETA reduced body weight, improved metabolic parameters, and attenuated tumor outcomes in obesity-associated pancreatic ductal adenocarcinoma First, impacts on PDAC demonstrated that both RETA and SEMA led to significant weight loss beginning one day after administration compared to vehicle (Veh, water) controls which remained weight stable (Fig
And I will say magnesium is a game changer for this as well, for motility
